Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.

International journal of immunogenetics - 1 Apr 2010

Chaves D, Belisário A, Castro G, Santoro M, Rodrigues C

Abstract excerpt

Antibodies that block factor VIII (FVIII) activity appear in some haemophilia A patients treated with FVIII replacement therapy and severely impaired treatment. To date, the mechanisms that lead to this immune response are unknown. In this work, haplotypes of cytokine interleukin 10 (IL-10) gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Factor Inhibitors
Share to Brazil
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Haplotypes

Share to Hemophilia A

Share to Interleukin-10

Share to Young Adult

Source

Identifiers

PMID: 20082647
DOI: 10.1111/j.1744-313X.2009.00893.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20082647-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.PMID 20082647Read ↗

The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.Semantic proximity Read ↗

Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients.Semantic proximity Read ↗

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.Semantic proximity Read ↗

New associations: INFG and TGFB1 genes and the inhibitor development in severe haemophilia A.Semantic proximity Read ↗

Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A.Semantic proximity Read ↗

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia ASemantic proximity Read ↗

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.Semantic proximity Read ↗

Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia ASemantic proximity Read ↗

Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A.Semantic proximity Read ↗

Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism.Semantic proximity Read ↗

Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia B.Semantic proximity Read ↗

Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.